In this episode of “Blood Cancer Talks,” hosts Ashwin Kishtagari, MD, and Edward Cliff, MD, are joined by guest Maximilian Stahl, MD, of the Dana-Farber Cancer Institute, to discuss imetelstat and luspatercept for the treatment of lower-risk myelodysplastic syndromes (MDS).
The episode discusses the following trials:
This podcast originally appeared on Blood Cancer Talks.